Literature DB >> 29752694

Ginkgo Leaf Extract and Dipyridamole Injection as Adjuvant Treatment for Angina Pectoris: A Meta-Analysis of 41 Randomized Controlled Trials.

Di Tan1, Jia-Rui Wu2, Ying-Ying Cui1, Yi Zhao1, Dan Zhang1, Shi Liu1, Bing Zhang1.   

Abstract

OBJECTIVE: To provide information about the effectiveness and safety of Ginkgo Leaf Extract and Dipyridamole Injection (GD) as one adjuvant therapy for treating angina pectoris (AP) and to evaluate the relevant randomized controlled trials (RCTs) with meta-analysis.
METHODS: RCTs concerning AP treated by GD were searched in China Biology Medicine Disc (SinoMed), PubMed, the China National Knowledge Infrastructure Database (CNKI), the Chinese Scientifific Journals Database (VIP), Wanfang Database, Embase, and the Cochrane Library, from inception to February, 2017. The Cochrane Risk Assessment Tool was adopted to assess the methodological quality of the RCTs. The Review Manager 5.3 software was utilized to conduct the meta-analysis.
RESULTS: A total of 41 RCTs involving 4,462 patients were included in the meta-analysis. The results indicated that the combined use of GD and Western medicine (WM) against AP was associated with a higher total effective rate [risk ratio (RR)=1.25, 95% confifidence interval (CI): 1.21-1.29, P<0.01], total effective rate of electrocardiogram (RR=1.29, 95% CI: 1.21-1.36, P<0.01). Additional, GD combined with WM could decrease the level of plasma viscosity [mean difference (MD)=-0.56, 95% CI:-0,81 to-0.30, P<0.01], fifibrinogen [MD=-1.02, 95% CI:-1.50 to-0.54, P<0.01], whole blood low shear viscosity [MD=-2.27, 95% CI:-3.04 to-1.49, P<0.01], and whole blood high shear viscosity (MD=-0.90, 95% CI: 1.37 to-0.44, P<0.01).
CONCLUSIONS: Comparing with receiving WM only, the combine use of GD and WM was associated with a better curative effect for patients with AP. Nevertheless, limited by the methodological quality of included RCTs more large-sample, multi-center RCTs were needed to confifirm our fifindings and provide further evidence for the clinical utility of GD.

Entities:  

Keywords:  Ginkgo Leaf Extract and Dipyridamole Injection; angina pectoris; meta-analysis; randomized controlled trials; systematic review

Mesh:

Substances:

Year:  2018        PMID: 29752694     DOI: 10.1007/s11655-018-2557-6

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  1 in total

1.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18
  1 in total
  5 in total

1.  Revealing the Common Mechanisms of Scutellarin in Angina Pectoris and Ischemic Stroke Treatment via a Network Pharmacology Approach.

Authors:  Zi-Qi Meng; Jia-Rui Wu; Ying-Li Zhu; Wei Zhou; Chang-Geng Fu; Xin-Kui Liu; Shu-Yu Liu; Meng-Wei Ni; Si-Yu Guo
Journal:  Chin J Integr Med       Date:  2020-05-22       Impact factor: 1.978

2.  Ginkgo leaf extract and dipyridamole injection for chronic cor pulmonale: a PRISMA-compliant meta-analysis of randomized controlled trials.

Authors:  Jian Qiu; Yijun Guo; Xin Xu; Hongmei Yue; Yapei Yang
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.840

3.  Combined therapy of hypertensive nephropathy with ginkgo leaf extract and dipyridamole injection and antihypertensive drugs: A systematic review and meta-analysis.

Authors:  Dinala Jialiken; Lichao Qian; Shuai Ren; Lihua Wu; Junyao Xu; Chong Zou
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

4.  Efficacy and Safety of Ginkgo Leaf Extract and Dipyridamole Injection for Ischemic Stroke: A Systematic Review and Meta Analysis.

Authors:  Ping Xue; Zhuoya Ma; Shuguang Liu
Journal:  Front Pharmacol       Date:  2019-12-04       Impact factor: 5.810

5.  Safety and Efficacy of Ginkgo-Damole and Nitroglycerin or Sodium Nitroprusside on Hypertensive Cerebropathies: A Meta-Analysis.

Authors:  Li Peng; Wei-Kun Zhao; Tong-Tong Xu; Qi Wu; Pan Lu; Pan-Pan Zhu; Xiao-Ming Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-04       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.